T. Rowe Price Associates »

Evommune shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $26M 1.1M 22.99
2025-12-31 $13M 782k 17.12

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
Rtw Investments
MPM Oncology Impact Management
Nan Fung Group Holdings
SymBiosis Capital Partners
Eventide Asset Management
T. Rowe Price Associates
Henderson Group
Marshall Wace
Baker Bros. Advisors
Alyeska Investment Group
Defilade Capital Management

View all funds holding Evommune